Package 0002-1442-11

Brand: omvoh

Generic: mirikizumab-mrkz
NDC Package

Package Facts

Identity

Package NDC 0002-1442-11
Digits Only 0002144211
Product NDC 0002-1442
Product ID 0002-1442_e1015232-2dfd-4b5d-b1d0-e0302e49c55a
Description

1 SYRINGE in 1 CARTON (0002-1442-11) / 2 mL in 1 SYRINGE (0002-1442-01)

Marketing

Marketing Status
Marketed Since 2025-10-23
Brand omvoh
Generic mirikizumab-mrkz
Sample Package No

Linked Drug Pages (1)

Omvoh ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["SUBCUTANEOUS"], "spl_id": "e1015232-2dfd-4b5d-b1d0-e0302e49c55a", "openfda": {"nui": ["N0000192799", "N0000192798"], "unii": ["Z7HVY03PHP"], "rxcui": ["2668391", "2668398", "2668405", "2668410", "2680728", "2680732", "2703047", "2703048", "2703049", "2703050", "2703051", "2703052", "2703053", "2703054"], "spl_set_id": ["472cbe04-263e-433d-9a0f-58c1b50b715a"], "pharm_class_epc": ["Interleukin-23 Antagonist [EPC]"], "pharm_class_moa": ["Interleukin-23 Antagonists [MoA]"], "manufacturer_name": ["Eli Lilly and Company"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE in 1 CARTON (0002-1442-11)  / 2 mL in 1 SYRINGE (0002-1442-01)", "package_ndc": "0002-1442-11", "marketing_start_date": "20251023"}], "brand_name": "Omvoh", "product_id": "0002-1442_e1015232-2dfd-4b5d-b1d0-e0302e49c55a", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Interleukin-23 Antagonist [EPC]", "Interleukin-23 Antagonists [MoA]"], "product_ndc": "0002-1442", "generic_name": "mirikizumab-mrkz", "labeler_name": "Eli Lilly and Company", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Omvoh", "active_ingredients": [{"name": "MIRIKIZUMAB", "strength": "100 mg/mL"}], "application_number": "BLA761279", "marketing_category": "BLA", "marketing_start_date": "20251023", "listing_expiration_date": "20261231"}